Related references
Note: Only part of the references are listed.Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity
Wenzhong Que et al.
APMIS (2012)
Effect of β-(3,4-Dihydroxyphenyl)Lactic Acid on Oxidative Stress Stimulated by High Glucose Levels in Human Peritoneal Mesothelial Cells
H. Zhang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Emerging therapies for the treatment of relapsed or refractory multiple myeloma
Meletios A. Dimopoulos et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
DEPTOR, an mTOR Inhibitor, Is a Physiological Substrate of SCFβTrCP E3 Ubiquitin Ligase and Regulates Survival and Autophagy
Yongchao Zhao et al.
MOLECULAR CELL (2011)
mTOR Generates an Auto-Amplification Loop by Triggering the βTrCP- and CK1α-Dependent Degradation of DEPTOR
Shanshan Duan et al.
MOLECULAR CELL (2011)
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study
Philippe Moreau et al.
BLOOD (2010)
mTOR and cancer: many loops in one pathway
Alejo Efeyan et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
DEPTOR expression and response to thalidomide: toward a new therapeutic target in multiple myeloma?
Javier de la Rubia et al.
LEUKEMIA & LYMPHOMA (2010)
High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma
Kevin D. Boyd et al.
LEUKEMIA & LYMPHOMA (2010)
Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235
Douglas W. McMillin et al.
CANCER RESEARCH (2009)
DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
Timothy R. Peterson et al.
CELL (2009)
Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation
Lindsey A. Allan et al.
FEBS JOURNAL (2009)
Real-time Fluorescent Quantitative Polymerase Chain Reaction Study of Polo-like Kinase-1 in Pterygia
H. Lu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2009)
Mammalian target of rapamycin and S6 kinase 1 positively regulate 6-thioguanine-induced autophagy
Xuehuo Zeng et al.
CANCER RESEARCH (2008)
MTORC1 signaling requires proteasomal function and the involvement of CUL4-DDB1 ubiquitin E3 ligase
Papia Ghosh et al.
CELL CYCLE (2008)
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients
DR Carrasco et al.
CANCER CELL (2006)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages
SP Zielske et al.
JOURNAL OF VIROLOGY (2005)
Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR
R Pullmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
PI3K/Akt/mTOR pathway as a target for cancer therapy
D Morgensztern et al.
ANTI-CANCER DRUGS (2005)
Targets and mechanisms for the regulation of translation in malignant transformation
MJ Clemens
ONCOGENE (2004)
Drug therapy: Multiple myeloma
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A system for stable expression of short interfering RNAs in mammalian cells
TR Brummelkamp et al.
SCIENCE (2002)
Share Paper
